Equities Research Analysts’ Updated EPS Estimates for February, 13th (ADR, ANTH, AOSL, APTO, ASPU, AUDC, AUG, GE, LBRT, NINE)

Equities Research Analysts’ updated eps estimates for Tuesday, February 13th:

Inter National Market Index (INDEXNYSEGIS:ADR) had its overweight rating reissued by analysts at Barclays PLC.

Anthera Pharmaceuticals (NASDAQ:ANTH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.75 price target on the stock. According to Zacks, “Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company’s clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren’s Syndrome, Graves’ Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California. “

Alpha and Omega Semiconductor (NASDAQ:AOSL) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Alpha and Omega Semiconductor Limited is engaged in designing, developing and supplying a broad range of power semiconductors globally, including a portfolio of Power MOSFET and Power IC products. The Company seeks to differentiate itself by integrating its expertise in device physics, process technology, design and advanced packaging to optimize product performance and cost. Its portfolio of products targets high-volume end-market applications, such as notebooks, netbooks, flat panel displays, mobile phone battery packs, set-top boxes, portable media players and power supplies. The products are incorporated into devices by original equipment manufacturers, or OEMs. The Company utilizes third-party foundries for all of its wafer fabrication and it deploys and implements its proprietary MOSFET processes at these third party foundries. The Company relies upon its in-house capacity and an associated provider for most of its packaging and testing requirements. “

Aptose Biosciences (NASDAQ:APTO) (TSE:APS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada. “

Aspen Group (NASDAQ:ASPU) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Aspen Group, Inc. is an online post-secondary education company. It offers certificate programs and associate, bachelor, master, and doctoral degree programs in a range of areas, including business and organization management, education, nursing, information technology, and general studies. Aspen Group, Inc. is headquartered in Denver, Colorado. “

AudioCodes (NASDAQ:AUDC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $8.50 price target on the stock. According to Zacks, “AUDIOCODES LTD designs, develops and markets enabling technologies and communication components for the transmission of voice, fax and modem over packet networks. Newly developed Voice over IP gateways as well as DSL and ATM access devices, enable packet networks to carry voice and data more efficiently and at lower cost than traditional telephone networks. They are a provider of voice over packet communication components that empower the development of equipment for these emerging markets. “

Auryn Resources (NYSEAMERICAN:AUG) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Auryn Resources Inc. is a mining exploration, acquisition and development company. Its project primarily includes the Committee Bay and Gibson MacQuoid gold projects located in Nunavut, the Homestake Ridge gold project in British Columbia and a portfolio of gold projects in southern Peru, through Corisur Peru SAC. Auryn Resources Inc. is based in Vancouver, Canada. “

General Electric (NYSE:GE) was given a $16.00 target price by analysts at Vertical Research. The firm currently has a hold rating on the stock.

Tudor Pickering initiated coverage on shares of Liberty Oilfield Services (NYSE:LBRT). The firm issued a buy rating on the stock.

Ninetowns Internet Technlgy Grp (NASDAQ:NINE) had its sector perform rating reissued by analysts at Scotiabank. The firm currently has a $29.00 price target on the stock.

Pacific Premier Bancorp (NASDAQ:PPBI) was given a $55.00 target price by analysts at Piper Jaffray Companies. The firm currently has a buy rating on the stock.

Qualys (NASDAQ:QLYS) was given a $70.00 price target by analysts at Northland Securities. The firm currently has a buy rating on the stock.

Oppenheimer Holdings Inc. initiated coverage on shares of Recro Pharma (NASDAQ:REPH). Oppenheimer Holdings Inc. issued a buy rating and a $19.00 price target on the stock.

RingCentral (NYSE:RNG) was given a $61.00 price target by analysts at Northland Securities. The firm currently has a buy rating on the stock.

Receive News & Ratings for Inter National Market Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inter National Market Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply